BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11888208)

  • 1. Identification of novel E2F1-regulated genes by microarray.
    Ma Y; Croxton R; Moorer RL; Cress WD
    Arch Biochem Biophys; 2002 Mar; 399(2):212-24. PubMed ID: 11888208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R; Ma Y; Song L; Haura EB; Cress WD
    Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
    Croxton R; Ma Y; Cress WD
    Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy.
    PĆ¼tzer BM; Stiewe T; Crespo F; Esche H
    Gene Ther; 2000 Aug; 7(15):1317-25. PubMed ID: 10918503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis.
    Polager S; Kalma Y; Berkovich E; Ginsberg D
    Oncogene; 2002 Jan; 21(3):437-46. PubMed ID: 11821956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proliferative and apoptotic activities of E2F1 in the mouse retina.
    Lin SC; Skapek SX; Papermaster DS; Hankin M; Lee EY
    Oncogene; 2001 Oct; 20(48):7073-84. PubMed ID: 11704831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.
    Fox EJ; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):307-13. PubMed ID: 12444919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell.
    Tsukuda K; Wiewrodt R; Molnar-Kimber K; Jovanovic VP; Amin KM
    Cancer Res; 2002 Jun; 62(12):3438-47. PubMed ID: 12067986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression phenotypic models that predict the activity of oncogenic pathways.
    Huang E; Ishida S; Pittman J; Dressman H; Bild A; Kloos M; D'Amico M; Pestell RG; West M; Nevins JR
    Nat Genet; 2003 Jun; 34(2):226-30. PubMed ID: 12754511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
    Dong YB; Yang HL; McMasters KM
    Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
    Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
    Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O; Benvenisty N
    Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
    McCabe MT; Davis JN; Day ML
    Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells.
    Iglesias AH; Camelo S; Hwang D; Villanueva R; Stephanopoulos G; Dangond F
    J Neuroimmunol; 2004 May; 150(1-2):163-77. PubMed ID: 15081262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners.
    Iwanaga R; Komori H; Ishida S; Okamura N; Nakayama K; Nakayama KI; Ohtani K
    Oncogene; 2006 Mar; 25(12):1786-98. PubMed ID: 16288221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.